Anzeige
Mehr »
Lynx Broker
Login
Dienstag, 19.11.2019 Börsentäglich über 12.000 News von 617 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PA3U ISIN: CA58410Q2036 Ticker-Symbol: P731 
Frankfurt
19.11.19
08:05 Uhr
2,500 Euro
-0,100
-3,85 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
MEDEXUS PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
MEDEXUS PHARMACEUTICALS INC 5-Tage-Chart

Aktuelle News zur MEDEXUS PHARMACEUTICALS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
22.10.Medexus Pharmaceuticals Inc: Medexus Pharmaceuticals to Present at the Dawson James Securities 5th Annual Small ...2
15.10.Medexus Pharmaceuticals Inc: Medexus's Chretien, Hebert resign2
MEDEXUS PHARMACEUTICALS Aktien ab 5,80 Euro handeln - Ohne versteckte Kosten!
15.10.Canaccord initiates coverage of Medexus Pharmaceuticals with Buy rating, C$6.50 price target2
19.09.Medexus Pharmaceuticals Inc: Medexus shareholders elect seven to board-
12.09.Medexus Pharmaceuticals Inc: Medexus's Gliolan receives recommendation for funding1
12.09.Medexus Pharmaceuticals receives boost for its Gliolan drug as Health Quality Ontario recommends public funding1
10.09.Discovery Investment Research Provides Update on Medexus Pharma263DIR Announces Availability of Research Update PHOENIX, AZ / ACCESSWIRE / September 10, 2019 / Discovery Investment Research (DIR), an equity research firm specializing in micro and small-cap stocks...
► Artikel lesen
22.08.Medexus Pharmaceuticals posts fiscal 1Q results showing healthy year-over-year rise in revenue2
22.08.Medexus Pharmaceuticals Inc: Medexus loses $2.2-million in fiscal Q1 20204
16.08.Medexus Pharmaceuticals Inc: Medexus to hold Q1 2020 results call Aug. 221
15.08.Medexus Pharmaceuticals Inc: Medexus Pharmaceuticals receives DTC eligibility1
17.07.Medexus Pharmaceuticals posts strong revenue numbers, trend to continue in 20193
08.07.Medexus Pharmaceuticals sees fiscal 4Q revenue rocket following successful acquisitions1
08.07.Medexus Pharmaceuticals reports Q4 results2
08.07.Medexus Pharmaceuticals Inc: Medexus talks fiscal 2019 revenue, omits P/L from NR2
28.06.Medexus Pharmaceuticals Inc: Medexus to hold fiscal 2019 results call July 8-
25.06.Medexus Pharmaceuticals adds veteran pharma executive to its board1
25.06.Medexus Pharmaceuticals Inc: Medexus appoints Gulfo to board1
11.03.Discover Investment Research: Discovery Investment Research (DIR) Announces Coverage of Medexus Pharmaceuticals32PHOENIX, AZ / ACCESSWIRE / March 11, 2019 / Discovery Investment Research (DIR), a leading micro-cap research firm, is pleased to announce coverage of its newest idea. For over 17 years, DIR has fulfilled...
► Artikel lesen
08.03.Medexus Pharmaceuticals Inc.: Medexus to Present at the 2019 LD Micro Virtual Conference42MONTREAL, CA / ACCESSWIRE / March 8, 2019 / Medexus Pharmaceuticals Inc. (the "Company" or "Medexus") (TSXV: MDP, OTCQB: PDDPF) today announced that it will be presenting at the second annual LD Micro...
► Artikel lesen
Seite:  Weiter >>
25 Nachrichten in den letzten 12 Monaten

Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1